A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
Bradley, Jessica M, Pablo Spaletra, Zhen Li, Thomas E Sharp, Traci T Goodchild, Laura G Corral, Leah Fung, et al. 2018. “A Novel Fibroblast Activation Inhibitor Attenuates Left Ventricular Remodeling and Preserves Cardiac Function in Heart Failure.”. American Journal of Physiology. Heart and Circulatory Physiology 315 (3): H563-H570.